Impact ofompk36genotype and KPC subtype on thein vitroactivity of ceftazidime/avibactam, imipenem/relebactam and meropenem/vaborbactam against KPC-producingK. pneumoniaeclinical isolates is a research paper published in JAC-Antimicrobial Resistance (2023). On theSindex it has a DataRank of 0. It has been cited 16 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
NIH
Grant: R21AI151363
NIAID NIH HHS
Grant: R03 AI144636
National Institutes of Health
Grant: 5R21AI151363-02
Use of site-specific pharmacokinetics to optimize antibiotic combinations and prevent the emergence of resistance against CRE
National Institutes of Health
Grant: 5R01AI127472-03
Enhanced Detection System for Healthcare-Associated Transmission of Infection
FWCI
1.24
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals